ID   FUCO_HUMAN              Reviewed;         466 AA.
AC   P04066; B2RBG3; Q14334; Q14335; Q3LID0; Q8NAC2;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 4.
DT   07-APR-2021, entry version 211.
DE   RecName: Full=Tissue alpha-L-fucosidase {ECO:0000305};
DE            EC=3.2.1.51 {ECO:0000305|PubMed:9741689};
DE   AltName: Full=Alpha-L-fucosidase I;
DE   AltName: Full=Alpha-L-fucoside fucohydrolase 1;
DE            Short=Alpha-L-fucosidase 1;
DE   Flags: Precursor;
GN   Name=FUCA1 {ECO:0000312|HGNC:HGNC:4006}; ORFNames=Nbla10230;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT FUCA1D ASP-65, AND VARIANT
RP   ARG-286.
RX   PubMed=8504303; DOI=10.1093/hmg/2.4.423;
RA   Seo H.-C., Willems P.J., Kretz K.A., Martin B.M., O'Brien J.S.;
RT   "Fucosidosis: four new mutations and a new polymorphism.";
RL   Hum. Mol. Genet. 2:423-429(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Neuroblastoma;
RX   PubMed=12880961; DOI=10.1016/s0304-3835(03)00085-5;
RA   Ohira M., Morohashi A., Nakamura Y., Isogai E., Furuya K., Hamano S.,
RA   Machida T., Aoyama M., Fukumura M., Miyazaki K., Suzuki Y., Sugano S.,
RA   Hirato J., Nakagawara A.;
RT   "Neuroblastoma oligo-capping cDNA project: toward the understanding of the
RT   genesis and biology of neuroblastoma.";
RL   Cancer Lett. 197:63-68(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-286.
RC   TISSUE=Spleen, and Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-466, AND VARIANT SER-269.
RX   PubMed=2803312; DOI=10.1016/0006-291x(89)91739-7;
RA   Occhiodoro T., Beckmann K.R., Morris C.P., Hopwood J.J.;
RT   "Human alpha-L-fucosidase: complete coding sequence from cDNA clones.";
RL   Biochem. Biophys. Res. Commun. 164:439-445(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-92.
RC   TISSUE=Placenta;
RX   PubMed=2174090; DOI=10.1007/bf01799583;
RA   Fukushima H., Nishimoto J., Okada S.;
RT   "Sequencing and expression of a full-length cDNA for human alpha-L-
RT   fucosidase.";
RL   J. Inherit. Metab. Dis. 13:761-765(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 75-427.
RX   PubMed=2983333; DOI=10.1073/pnas.82.4.1262;
RA   Fukushima H., de Wet J.R., O'Brien J.S.;
RT   "Molecular cloning of a cDNA for human alpha-L-fucosidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:1262-1265(1985).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 75-426.
RX   PubMed=6096099; DOI=10.1089/dna.1.1984.3.437;
RA   de Wet J.R., Fukushima H., Dewji N.N., Wilcox E., O'Brien J.S.,
RA   Helinski D.R.;
RT   "Chromogenic immunodetection of human serum albumin and alpha-L-fucosidase
RT   clones in a human hepatoma cDNA expression library.";
RL   DNA 3:437-447(1984).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 75-426, AND VARIANT SER-269.
RX   PubMed=2894306; DOI=10.1159/000469189;
RA   O'Brien J.S., Willems P.J., Fukushima H., de Wet J.R., Darby J.K.,
RA   Dicioccio R.A., Fowler M.L., Shows T.B.;
RT   "Molecular biology of the alpha-6L-fucosidase gene and fucosidosis.";
RL   Enzyme 38:45-53(1987).
RN   [11]
RP   STRUCTURE OF CARBOHYDRATES.
RA   Beem E.P., Lisman J.J.W., van Steijn G.J., van der Wal C.J.,
RA   Trippelvitz L.A.W., Overdijk B., van Halbeek H., Mutsaers J.H.G.M.,
RA   Vliegenthart J.F.G.;
RT   "Structural analysis of the carbohydrate moieties of alpha-L-fucosidase
RT   from human liver.";
RL   Glycoconj. J. 4:33-42(1987).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9741689;
RA   Asfaw B., Schindler D., Ledvinova J., Cerny B., Smid F., Conzelmann E.;
RT   "Degradation of blood group A glycolipid A-6-2 by normal and mutant human
RT   skin fibroblasts.";
RL   J. Lipid Res. 39:1768-1780(1998).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-241 AND ASN-382.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-170, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   VARIANT ARG-286.
RX   PubMed=8399358; DOI=10.1016/0925-4439(93)90065-9;
RA   Yang M., Allen H., Dicioccio R.A.;
RT   "Pedigree analysis of alpha-L-fucosidase gene mutations in a fucosidosis
RT   family.";
RL   Biochim. Biophys. Acta 1182:245-249(1993).
RN   [19]
RP   VARIANT FUCA1D LEU-68.
RX   PubMed=7874128;
RA   Seo H.-C., Yang M., Tonlorenzi R., Willems P.J., Kim A.H., Filocamo M.,
RA   Gatti R., Dicioccio R.A., O'Brien J.S.;
RT   "A missense mutation (S63L) in alpha-L-fucosidase is responsible for
RT   fucosidosis in an Italian patient.";
RL   Hum. Mol. Genet. 3:2065-2066(1994).
RN   [20]
RP   VARIANT ARG-286.
RX   PubMed=7815431; DOI=10.1136/jmg.31.8.659-a;
RA   Cragg H., Winchester B., Seo H.-C., O'Brien J.S., Swallow D.;
RT   "Molecular basis of the common electrophoretic polymorphism (Fu1/Fu2) in
RT   human alpha-L-fucosidase.";
RL   J. Med. Genet. 31:659-660(1994).
RN   [21]
RP   VARIANT FUCA1D ARG-410.
RX   PubMed=9762612; DOI=10.1023/a:1005405222252;
RA   Fleming C.J., Sinclair D.U., White E.J., Winchester B., Whiteford M.L.,
RA   Connor J.M.;
RT   "A fucosidosis patient with relative longevity and a missense mutation in
RT   exon 7 of the alpha-fucosidase gene.";
RL   J. Inherit. Metab. Dis. 21:688-689(1998).
RN   [22]
RP   REVIEW ON VARIANTS.
RX   PubMed=10094192; DOI=10.1038/sj.ejhg.5200272;
RA   Willems P.J., Seo H.-C., Coucke P., Tonlorenzi R., O'Brien J.S.;
RT   "Spectrum of mutations in fucosidosis.";
RL   Eur. J. Hum. Genet. 7:60-67(1999).
RN   [23]
RP   VARIANTS SER-269 AND ARG-286.
RX   PubMed=12408193; DOI=10.1023/a:1020116220624;
RA   Ip P., Goh W., Chan K.W., Cheung P.T.;
RT   "A novel FUCA1 mutation causing fucosidosis in a Chinese boy.";
RL   J. Inherit. Metab. Dis. 25:415-416(2002).
CC   -!- FUNCTION: Alpha-L-fucosidase is responsible for hydrolyzing the alpha-
CC       1,6-linked fucose joined to the reducing-end N-acetylglucosamine of the
CC       carbohydrate moieties of glycoproteins. {ECO:0000269|PubMed:9741689}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-L-fucoside + H2O = an alcohol + L-fucose;
CC         Xref=Rhea:RHEA:12288, ChEBI:CHEBI:2181, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:28349, ChEBI:CHEBI:30879; EC=3.2.1.51;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10054};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12289;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E)) + H2O = a
CC         neolactoside nLc4Cer(d18:1(4E)) + L-fucose; Xref=Rhea:RHEA:48224,
CC         ChEBI:CHEBI:2181, ChEBI:CHEBI:15377, ChEBI:CHEBI:17006,
CC         ChEBI:CHEBI:28691; Evidence={ECO:0000269|PubMed:9741689};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48225;
CC         Evidence={ECO:0000269|PubMed:9741689};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:0) + H2O = a
CC         neolactoside nLc4Cer(d18:0) + L-fucose; Xref=Rhea:RHEA:49308,
CC         ChEBI:CHEBI:2181, ChEBI:CHEBI:15377, ChEBI:CHEBI:91119,
CC         ChEBI:CHEBI:91121; Evidence={ECO:0000269|PubMed:9741689};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49309;
CC         Evidence={ECO:0000269|PubMed:9741689};
CC   -!- SUBUNIT: Homotetramer.
CC   -!- INTERACTION:
CC       P04066; Q99828: CIB1; NbExp=3; IntAct=EBI-2512153, EBI-372594;
CC       P04066; Q9BTT4: MED10; NbExp=3; IntAct=EBI-2512153, EBI-394354;
CC       P04066; Q9UHD9: UBQLN2; NbExp=5; IntAct=EBI-2512153, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:9741689}.
CC   -!- POLYMORPHISM: There are two common alleles of FUCA1; FUCA1*1; also
CC       known as Fu1; has Arg-281 and FUCA1*2; also known as Fu2; has Gln-281.
CC   -!- DISEASE: Fucosidosis (FUCA1D) [MIM:230000]: An autosomal recessive
CC       lysosomal storage disease characterized by accumulation of fucose-
CC       containing glycolipids and glycoproteins in various tissues. Clinical
CC       signs include facial dysmorphism, dysostosis multiplex, moderate
CC       hepatomegaly, severe intellectual deficit, deafness, and according to
CC       age, angiokeratomas. {ECO:0000269|PubMed:7874128,
CC       ECO:0000269|PubMed:8504303, ECO:0000269|PubMed:9762612}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 29 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA35519.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA52481.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH17338.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG37210.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA25646.1; Type=Miscellaneous discrepancy; Note=Translation of X01390 sequence produces a larger peptide than that shown in CAA25646.1.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M80815; AAA52481.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M80809; AAA52481.1; JOINED; Genomic_DNA.
DR   EMBL; M80810; AAA52481.1; JOINED; Genomic_DNA.
DR   EMBL; M80811; AAA52481.1; JOINED; Genomic_DNA.
DR   EMBL; M80812; AAA52481.1; JOINED; Genomic_DNA.
DR   EMBL; M80813; AAA52481.1; JOINED; Genomic_DNA.
DR   EMBL; M80814; AAA52481.1; JOINED; Genomic_DNA.
DR   EMBL; AB074175; BAE45738.1; -; mRNA.
DR   EMBL; AK092914; BAC04002.1; -; mRNA.
DR   EMBL; AK314649; BAG37210.1; ALT_INIT; mRNA.
DR   EMBL; AL590728; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017338; AAH17338.1; ALT_INIT; mRNA.
DR   EMBL; M29877; AAA35519.1; ALT_INIT; mRNA.
DR   EMBL; M10355; AAA52482.1; -; mRNA.
DR   EMBL; X01390; CAA25646.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS244.2; -.
DR   PIR; A33427; HWHUFA.
DR   RefSeq; NP_000138.2; NM_000147.4.
DR   SMR; P04066; -.
DR   BioGRID; 108793; 18.
DR   IntAct; P04066; 16.
DR   MINT; P04066; -.
DR   STRING; 9606.ENSP00000363603; -.
DR   BindingDB; P04066; -.
DR   ChEMBL; CHEMBL4176; -.
DR   SwissLipids; SLP:000001407; -.
DR   CAZy; GH29; Glycoside Hydrolase Family 29.
DR   GlyConnect; 1810; 6 N-Linked glycans (2 sites).
DR   GlyGen; P04066; 3 sites.
DR   iPTMnet; P04066; -.
DR   MetOSite; P04066; -.
DR   PhosphoSitePlus; P04066; -.
DR   BioMuta; FUCA1; -.
DR   DMDM; 156631012; -.
DR   CPTAC; CPTAC-2215; -.
DR   EPD; P04066; -.
DR   jPOST; P04066; -.
DR   MassIVE; P04066; -.
DR   MaxQB; P04066; -.
DR   PaxDb; P04066; -.
DR   PeptideAtlas; P04066; -.
DR   PRIDE; P04066; -.
DR   ProteomicsDB; 51645; -.
DR   Antibodypedia; 30233; 288 antibodies.
DR   DNASU; 2517; -.
DR   Ensembl; ENST00000374479; ENSP00000363603; ENSG00000179163.
DR   GeneID; 2517; -.
DR   KEGG; hsa:2517; -.
DR   UCSC; uc001bie.5; human.
DR   CTD; 2517; -.
DR   DisGeNET; 2517; -.
DR   GeneCards; FUCA1; -.
DR   HGNC; HGNC:4006; FUCA1.
DR   HPA; ENSG00000179163; Low tissue specificity.
DR   MalaCards; FUCA1; -.
DR   MIM; 230000; phenotype.
DR   MIM; 612280; gene.
DR   neXtProt; NX_P04066; -.
DR   OpenTargets; ENSG00000179163; -.
DR   Orphanet; 349; Fucosidosis.
DR   PharmGKB; PA28422; -.
DR   VEuPathDB; HostDB:ENSG00000179163.11; -.
DR   eggNOG; KOG3340; Eukaryota.
DR   GeneTree; ENSGT00440000035378; -.
DR   HOGENOM; CLU_002934_1_1_1; -.
DR   InParanoid; P04066; -.
DR   OMA; WHWQGQQ; -.
DR   OrthoDB; 929780at2759; -.
DR   PhylomeDB; P04066; -.
DR   TreeFam; TF313034; -.
DR   BRENDA; 3.2.1.51; 2681.
DR   PathwayCommons; P04066; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-975578; Reactions specific to the complex N-glycan synthesis pathway.
DR   SABIO-RK; P04066; -.
DR   BioGRID-ORCS; 2517; 10 hits in 994 CRISPR screens.
DR   ChiTaRS; FUCA1; human.
DR   GeneWiki; Fucosidase; -.
DR   GenomeRNAi; 2517; -.
DR   Pharos; P04066; Tchem.
DR   PRO; PR:P04066; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P04066; protein.
DR   Bgee; ENSG00000179163; Expressed in colon and 245 other tissues.
DR   Genevisible; P04066; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0004560; F:alpha-L-fucosidase activity; IDA:UniProtKB.
DR   GO; GO:0006004; P:fucose metabolic process; IDA:UniProtKB.
DR   GO; GO:0019377; P:glycolipid catabolic process; ISS:BHF-UCL.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; NAS:UniProtKB.
DR   GO; GO:0016139; P:glycoside catabolic process; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 2.60.40.1180; -; 1.
DR   InterPro; IPR016286; FUC_metazoa-typ.
DR   InterPro; IPR028755; FUCA1.
DR   InterPro; IPR031919; Fucosidase_C.
DR   InterPro; IPR000933; Glyco_hydro_29.
DR   InterPro; IPR018526; Glyco_hydro_29_CS.
DR   InterPro; IPR013780; Glyco_hydro_b.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR10030; PTHR10030; 1.
DR   PANTHER; PTHR10030:SF2; PTHR10030:SF2; 1.
DR   Pfam; PF01120; Alpha_L_fucos; 1.
DR   Pfam; PF16757; Fucosidase_C; 1.
DR   PIRSF; PIRSF001092; Alpha-L-fucosidase; 1.
DR   PRINTS; PR00741; GLHYDRLASE29.
DR   SMART; SM00812; Alpha_L_fucos; 1.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   PROSITE; PS00385; ALPHA_L_FUCOSIDASE; 1.
PE   1: Evidence at protein level;
KW   Disease variant; Glycoprotein; Glycosidase; Hydrolase; Lysosome;
KW   Phosphoprotein; Reference proteome; Signal.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..466
FT                   /note="Tissue alpha-L-fucosidase"
FT                   /id="PRO_0000010308"
FT   SITE            296
FT                   /note="May be important for catalysis"
FT   MOD_RES         170
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   CARBOHYD        241
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        268
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VARIANT         2
FT                   /note="R -> W (in dbSNP:rs2070955)"
FT                   /id="VAR_049106"
FT   VARIANT         10
FT                   /note="P -> R (in dbSNP:rs2070956)"
FT                   /id="VAR_016233"
FT   VARIANT         65
FT                   /note="G -> D (in FUCA1D; loss of activity;
FT                   dbSNP:rs1353778985)"
FT                   /evidence="ECO:0000269|PubMed:8504303"
FT                   /id="VAR_002442"
FT   VARIANT         68
FT                   /note="S -> L (in FUCA1D)"
FT                   /evidence="ECO:0000269|PubMed:7874128"
FT                   /id="VAR_002443"
FT   VARIANT         146
FT                   /note="P -> L (in dbSNP:rs2228424)"
FT                   /id="VAR_049107"
FT   VARIANT         260
FT                   /note="V -> I (in dbSNP:rs665)"
FT                   /id="VAR_049108"
FT   VARIANT         269
FT                   /note="C -> S (in dbSNP:rs1126512)"
FT                   /evidence="ECO:0000269|PubMed:12408193,
FT                   ECO:0000269|PubMed:2803312, ECO:0000269|PubMed:2894306"
FT                   /id="VAR_016234"
FT   VARIANT         286
FT                   /note="Q -> R (in allele FUCA1*2; dbSNP:rs13551)"
FT                   /evidence="ECO:0000269|PubMed:12408193,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:7815431,
FT                   ECO:0000269|PubMed:8399358, ECO:0000269|PubMed:8504303"
FT                   /id="VAR_002444"
FT   VARIANT         410
FT                   /note="L -> R (in FUCA1D; less than 1% of residual
FT                   activity; dbSNP:rs80358199)"
FT                   /evidence="ECO:0000269|PubMed:9762612"
FT                   /id="VAR_016235"
FT   CONFLICT        54..56
FT                   /note="DEA -> NEV (in Ref. 3; BAC04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        74
FT                   /note="S -> T (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        76..77
FT                   /note="WF -> FL (in Ref. 8; AAA52482 and 9; CAA25646)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93..114
FT                   /note="Missing (in Ref. 3; BAC04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="A -> T (in Ref. 3; BAC04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171
FT                   /note="A -> G (in Ref. 3; BAC04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="N -> D (in Ref. 3; BAC04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        427
FT                   /note="Q -> P (in Ref. 8; AAA52482)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   466 AA;  53689 MW;  D9A38ECC7BADCBBB CRC64;
     MRAPGMRSRP AGPALLLLLL FLGAAESVRR AQPPRRYTPD WPSLDSRPLP AWFDEAKFGV
     FIHWGVFSVP AWGSEWFWWH WQGEGRPQYQ RFMRDNYPPG FSYADFGPQF TARFFHPEEW
     ADLFQAAGAK YVVLTTKHHE GFTNWPSPVS WNWNSKDVGP HRDLVGELGT ALRKRNIRYG
     LYHSLLEWFH PLYLLDKKNG FKTQHFVSAK TMPELYDLVN SYKPDLIWSD GEWECPDTYW
     NSTNFLSWLY NDSPVKDEVV VNDRWGQNCS CHHGGYYNCE DKFKPQSLPD HKWEMCTSID
     KFSWGYRRDM ALSDVTEESE IISELVQTVS LGGNYLLNIG PTKDGLIVPI FQERLLAVGK
     WLSINGEAIY ASKPWRVQWE KNTTSVWYTS KGSAVYAIFL HWPENGVLNL ESPITTSTTK
     ITMLGIQGDL KWSTDPDKGL FISLPQLPPS AVPAEFAWTI KLTGVK
//
